Targeting the NFκB signaling pathways for breast cancer prevention and therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Medicinal Chemistry

• Publication date

  2014-12-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/0929867321666141106124315PMID 25386819PMCID PMC6690202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple myeloma maintenance therapy: A review of the pharmacologic treatment

  2015cited by this paper
• Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets

  2014influential reference
• Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-κB-dependent MMP-9 expression

  2014cited by this paper
• Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.

  2014cited by this paper
• Breast cancer statistics, 2013

  2014cited by this paper
• Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer

  2014cited by this paper
• Inflammation and pancreatic cancer: disease promoter and new therapeutic target

  2014cited by this paper
• Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer

  2014cited by this paper
• Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.

  2014cited by this paper
• Epithelial–mesenchymal transition in human gastric cancer cell lines induced by TNF‐α‐inducing protein of Helicobacter pylori

  2014cited by this paper
• NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

  2013cited by this paper
• Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients

  2013cited by this paper
• Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin

  2013cited by this paper
• Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.

  2013cited by this paper
• Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.

  2013cited by this paper
• Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.

  2013cited by this paper
• A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer

  2013cited by this paper
• β1-integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer

  2013cited by this paper
• Role of NF‐κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells

  2013cited by this paper
• NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.

  2013cited by this paper
• Aspirin and Breast Cancer Prevention

  2013cited by this paper
• Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells

  2013cited by this paper
• Matrix metalloproteinase-9 as a potential tumor marker in breast cancer.

  2013cited by this paper
• Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.

  2013cited by this paper
• Genetically engineered mouse models of PI3K signaling in breast cancer

  2013cited by this paper
• Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma.

  2013cited by this paper
• Role of cancer-related inflammation in esophageal cancer.

  2013cited by this paper
• IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.

  2013cited by this paper
• miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.

  2013cited by this paper
• A20-mediated negative regulation of canonical NF-κB signaling pathway

  2013cited by this paper
• Denosumab for the treatment of bone metastases in advanced breast cancer.

  2013cited by this paper
• The Effect of Curcumin on Breast Cancer Cells

  2013cited by this paper
• Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling

  2013cited by this paper
• Targeting the NF-κB pathway in cancer therapy.

  2013influential reference
• Sex hormone receptors in breast cancer.

  2013cited by this paper
• The nuclear factor‐κB pathway down‐regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor‐κB inhibitors in cancer therapy

  2013cited by this paper
• Canonical and Non-Canonical NF-κB Signaling Promotes Breast Cancer Tumor-Initiating Cells

  2013cited by this paper
• Using DelPhi capabilities to mimic protein's conformational reorganization with amino acid specific dielectric constants.

  2013cited by this paper
• Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

  2013cited by this paper
• Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors

  2013cited by this paper
• Oestrogen receptors in breast cancer: basic mechanisms and clinical implications

  2013cited by this paper
• Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer

  2013cited by this paper
• The complexity of NF-κB signaling in inflammation and cancer

  2013cited by this paper
• Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence

  2013cited by this paper
• Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF-κB

  2013cited by this paper
• ESR1 ligand binding domain mutations in hormone-resistant breast cancer

  2013cited by this paper
• Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells

  2013cited by this paper
• Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP‐ribose) polymerase cleavage and inhibiting nuclear factor kappa‐B activity

  2013cited by this paper
• Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil

  2013cited by this paper
• P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency.

  2013cited by this paper
• Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

  2013cited by this paper
• Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis.

  2013cited by this paper
• IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model

  2013cited by this paper
• Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line

  2013cited by this paper
• MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

  2012cited by this paper
• Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages.

  2012cited by this paper
• Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.

  2012cited by this paper
• Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.

  2012cited by this paper
• NF-κB signaling pathway and free radical impact.

  2012cited by this paper
• Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma

  2012cited by this paper
• Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

  2012cited by this paper
• Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective.

  2012cited by this paper
• The diverse and complex roles of NF-κB subunits in cancer

  2012cited by this paper
• p53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseases.

  2012cited by this paper
• NFκB signaling is important for growth of antiestrogen resistant breast cancer cells

  2012cited by this paper
• Histone deacetylase inhibitors as cancer therapeutics

  2012cited by this paper
• TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production

  2012cited by this paper
• Histone deacetylase inhibitors and rational combination therapies.

  2012cited by this paper
• DNA Damage Induces NF-κB-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion*

  2012cited by this paper
• NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression*

  2012cited by this paper
• Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.

  2012cited by this paper
• Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion

  2012cited by this paper
• Inhibitory kappa B kinases as targets for pharmacological regulation

  2012cited by this paper
• The proteasome: molecular machinery and pathophysiological roles

  2012cited by this paper
• Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.

  2012cited by this paper
• Radiation-Triggered NF-κB Activation is Responsible for the Angiogenic Signaling Pathway and Neovascularization for Breast Cancer Cell Proliferation and Growth

  2012cited by this paper
• Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression

  2012cited by this paper
• NF‐κB and the link between inflammation and cancer

  2012cited by this paper
• Proteasome inhibitors: an expanding army attacking a unique target.

  2012cited by this paper
• TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

  2012cited by this paper
• Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer

  2012cited by this paper
• Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.

  2012cited by this paper
• Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action

  2012cited by this paper
• The interaction between ER and NFκB in resistance to endocrine therapy

  2012influential reference
• Charting the NF-κB Pathway Interactome Map

  2012cited by this paper
• Molecular Pathways Molecular Pathways : VCAM-1 as a Potential Therapeutic Target in Metastasis

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer

  2012cited by this paper
• Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.

  2012cited by this paper
• Non-canonical NF-κB signaling pathway

  2011cited by this paper
• Colon cancer-derived factors activate NF-κB in myeloid cells via TLR2 to link inflammation and tumorigenesis.

  2011cited by this paper
• Molecular Pathways: Targeting Proteasomal Protein Degradation in Cancer

  2011cited by this paper
• Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

  2011cited by this paper
• Inflammation meets cancer, with NF-κB as the matchmaker

  2011cited by this paper
• Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.

  2011cited by this paper
• Cytokines, inflammation and colon cancer.

  2011cited by this paper
• Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer

  2011cited by this paper
• Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

  2011cited by this paper
• NF-κB addiction and its role in cancer: ‘one size does not fit all’

  2011cited by this paper
• NF-κB, stem cells and breast cancer: the links get stronger

  2011cited by this paper

• Dissecting Context-Specific Effects of ERK5 Signaling in Triple-Negative Breast Cancer

  2026cites this paper
• Impact of type 2 diabetes on malignancies of the female reproductive system.

  2026cites this paper
• Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast Cancer

  2025cites this paper
• HOXA10 and HOXA11 in Human Endometrial Benign Disorders: Unraveling Molecular Pathways and Their Impact on Reproduction

  2025cites this paper
• GAS5 as a therapeutic target in breast cancer through apoptosis induction

  2025cites this paper
• The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma

  2025cites this paper
• Evaluating the therapeutic potential of picrosides in breast cancer cell lines: a systematic scoping review.

  2025cites this paper
• The dual facets of MiRNA in modulating NF-κB in breast cancer

  2025cites this paper
• Phallus indusiatus Extracts Promoted MCF-7 Apoptosis Under TNFα-induced Tumor Microenvironment by Attenuating NF-kappaB and Akt Activation

  2025cites this paper
• Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia

  2025cites this paper
• Linarin inhibits survival and metastasis in triple-negative breast cancer cell line MDA-MB-231 by downregulating NF-κB p-p65/MMP-9, upregulating Bax, and enhancing Caspase 3/7 expression

  2025cites this paper
• Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies

  2025cites this paper
• Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression.

  2025cites this paper
• Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer.

  2025cites this paper
• Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements

  2025cites this paper
• Combined Phytochemical Sulforaphane and Dietary Fiber Inulin Contribute to the Prevention of ER-Negative Breast Cancer via PI3K/AKT/MTOR Pathway and Modulating Gut Microbial Composition

  2025cites this paper
• Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells.

  2025cites this paper
• Natural Dietary Compounds Targeting NF‐κB Signaling in Cancer: Implications for Nutrition‐Based Prevention and Therapy

  2025cites this paper
• The recombinant anti-MET/EpCAM bispecific antibody fragment: a promising novel therapeutic approach for breast cancer treatment

  2025cites this paper
• Structure‐Driven Mechanisms and Synergistic Approaches of Polyphyllin VII in Breast Cancer Therapy

  2025cites this paper
• Identifying the Impact of RelA Overexpression in Triple‐Negative Breast Cancer Cells Using Mass Spectroscopy‐based Proteomics and Metabolomics Analysis

  2025cites this paper
• Metabolism and Excretion of 8-O-Acetylharpagide in Rats and Identification of Its Potential Anti-Breast Cancer Active Metabolites

  2025cites this paper
• Damnacanthal Exerts Anti-Cancer Effects in Breast Cancer Cells via NAG-1 Upregulation, CRM1 Downregulation, and Induction of Autophagy.

  2025cites this paper
• Revisiting multi-pathway modulation with theophylline derivatives: Targeting STAT3, NF-κB, and apoptotic signaling in breast cancer.

  2025cites this paper
• Unveiling role of oncogenic signalling pathways in complicating breast cancer

  2025cites this paper
• The Unseen Enemies: Harnessing the Role of Neutrophil Extracellular Traps in Breast Cancer Progression, Immune Evasion, and Treatment Resistance.

  2025cites this paper
• Phytochemicals in Breast Cancer Therapy: Decoding Molecular Pathways and Pioneering Therapeutic Strategies

  2025cites this paper
• Protective effect of pH-sensitive carvacrol zinc oxide quantum dots on Nrf-2, MAPK and NF-κB pathways and protein-bound carbohydrates in DMBA-induced mammary carcinogenesis.

  2025cites this paper
• Decoding breast cancer: insights into molecular pathways & therapeutic approaches

  2025cites this paper
• Innovative approaches in breast cancer therapy: repurposing nanocarriers for enhanced outcomes

  2025cites this paper
• Exploring the antineoplastic potential of novel NSAID derivatives in combatting mammary tumorigenesis: a comprehensive review

  2025cites this paper
• Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer

  2025cites this paper
• Interplay Between Key Molecular Signaling Pathways and Immune Players Following Brain Irradiation

  2025cites this paper
• Comprehensive Meta-Analysis of 28 miRNA-SNPs Reveals First Pooled Evidence for Five Variants Associated with Breast Cancer Susceptibility.

  2025cites this paper
• Role of Hypoxia Induced by Medicinal Plants; A Revolutionary Era of Cellular and Molecular Herbal Medicine in Neuroblastoma Treatment.

  2024cites this paper
• Therapeutic implications of the interplay between interferons and ER in breast cancer.

  2024cites this paper
• stMMR: accurate and robust spatial domain identification from spatially resolved transcriptomics with multimodal feature representation

  2024cites this paper
• New insights into the anticancer effects of Polycladia crinita aqueous extract and its selenium nanoformulation against the solid Ehrlich carcinoma model in mice via VEGF, notch 1, NF-кB, cyclin D1, and caspase 3 signaling pathway

  2024cites this paper
• Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review.

  2024cites this paper
• Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer

  2024cites this paper
• ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-κB-MAGE-A6 Pathway

  2024cites this paper
• Evaluation the Levels of Yap1 Protein and NF-Κb in Serum of Women with Breast Cancer

  2024cites this paper
• Isoorientin Suppresses Invasion of Breast and Colon Cancer Cells by Inhibition of CXC Chemokine Receptor 4 Expression

  2024cites this paper
• Double-Edged Sword Effect of Diet and Nutrition on Carcinogenic Molecular Pathways in Breast Cancer

  2024cites this paper
• Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy

  2024cites this paper
• Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation

  2024cites this paper
• Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS‐Dependent Akt/β‐Catenin Signaling Pathway

  2024cites this paper
• The potential therapeutic role of curcumin in osteoporosis treatment: based on multiple signaling pathways

  2024cites this paper
• Gliotoxin triggers cell death through multifaceted targeting of cancer-inducing genes in breast cancer therapy

  2024cites this paper
• Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review.

  2024cites this paper
• The Binding Capacity of the Lead Phytochemical Molecule to Cancer Cell Target Proteins and its Potential Anticancer Properties with Respect to Standard Drugs

  2024cites this paper
• Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model

  2024cites this paper
• A Review on Picrosides Targeting NFκB and its Proteins for Treatment of Breast Cancer

  2024cites this paper
• Noscapine and Apoptosis in Breast and Other Cancers

  2024cites this paper
• Global Interactome Mapping Reveals Pro-tumorigenic Interactions of NF-κB in Breast Cancer

  2024cites this paper
• Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers

  2024cites this paper
• Impact of Lipid-Lowering Therapy on Cancer Risk: A Narrative Review.

  2024cites this paper
• Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy

  2024cites this paper
• Systematic Review and Meta-analysis Indicating Curcumin to Enhance the Synergistic Potential of Paclitaxel and Reduce Cell Viability, Tumor Volume, and Drug Resistance in Different Cancers.

  2024cites this paper
• Cardamonin anticancer effects through the modulation of the tumor immune microenvironment in triple-negative breast cancer cells.

  2024cites this paper
• Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression

  2024cites this paper
• MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer

  2024cites this paper
• A systems biology-based study to assess the effects of TNF-alpha ± apigenin in triple-negative breast cancer cell line

  2024cites this paper
• Comparative analyses of gene networks mediating cancer metastatic potentials across lineage types

  2024cites this paper
• Estrogen Sulfotransferase (SULT1E1) and NFκβ Confer Matrix Metalloprotease (MMP 2/9) Action in Breast Carcinogenesis

  2024cites this paper
• Progress in the discovery and development of anticancer agents from marine cyanobacteria

  2024cites this paper
• Nanotherapeutic strategy against glioblastoma using enzyme inhibitors.

  2024cites this paper
• Curcumin Administration Routes in Breast Cancer Treatment

  2024cites this paper
• Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer

  2024cites this paper
• Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast Cancer

  2024cites this paper
• Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer

  2024cites this paper
• Gold Nanoparticles Downregulate IL-6 Expression/Production by Upregulating microRNA-26a-5p and Deactivating the RelA and NF-κBp50 Transcription Pathways in Activated Breast Cancer Cells

  2024cites this paper
• Combining Water‐Soluble Porphyrin and Phthalocyanine Photosensitizers With Doxorubicin Improves the Efficacy of Chemo‐Photodynamic Therapy Against DMBA‐Induced Breast Carcinoma

  2024cites this paper
• Monoacylglycerol lipase inhibitor JJKK048 ameliorates ABCG2 transporter-mediated regorafenib resistance induced by hypoxia in triple negative breast cancer cells.

  2023cites this paper
• Non-coding RNAs mediated inflammation in breast cancers.

  2023cites this paper
• Distinct invasive patterns in situ between estrogen receptor‐positive and triple‐negative breast cancer through the intraductal tracking of carbon nanoparticles

  2023cites this paper
• Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations

  2023cites this paper
• Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers

  2023cites this paper
• The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy.

  2023cites this paper
• Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics

  2023cites this paper
• Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression

  2023cites this paper
• Cyclooxygenase-2 as a therapeutic target against human breast cancer: A comprehensive review.

  2023cites this paper
• The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer

  2023cites this paper
• Inflammatory Networks in Renal Cell Carcinoma

  2023cites this paper
• Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis

  2023cites this paper
• Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors.

  2023cites this paper
• The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway

  2023cites this paper
• Role of macrophages in cancer progression and targeted immunotherapies.

  2023cites this paper
• Decoding the role of S100 proteins in mammary gland regulation and their role in breast cancer metastasis

  2023cites this paper
• Tailoring therapies to counter the divergent immune landscapes of breast cancer

  2023cites this paper
• Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women

  2023cites this paper
• Cytotoxic and anti-metastatic action mediates the anti-proliferative activity of Rhazya stricta Decne inducing apoptotic cell death in human cancer cells: Implication in chemopreventive mechanism

  2023cites this paper
• Structures and bioactivities of monomeric and dimeric carvotacetones from Sphaeranthus africanus.

  2023cites this paper
• Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review

  2023cites this paper
• The potential value of some adipokines and cytokines as diagnostic biomarkers for prostate cancer

  2023cites this paper
• Role of The circ-HIPK3, circ-PVT1, miR-25, and miR-149 in Response of Breast Cancer Cells to Ionizing Radiation

  2023cites this paper
• Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer

  2023cites this paper
• Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3k-AKT/STAT3 Signaling.

  2023cites this paper
• Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment

  2023cites this paper
• Suppressing Src-Mediated EGFR Signaling by Sustained Calcium Supply Targeting Triple-Negative Breast Cancer

  2023influential citation